We Live Science.
to one of the most innovative locations for science in the Berlin-Brandenburg metropolitan region. At the Potsdam Science Park, top international research meets excellent education and research-related production. Research institutions such as the Max Planck and Fraunhofer Institutes, the University of Potsdam, the Brandenburg State Archives and more than 30 companies and start-ups jointly create a “Campus of the Future” here in Potsdam-Golm.
More than 12,500 people conduct research, work and study here in the fields of biotechnology, medical technology, optics, geosciences, astrophysics and gravitational physics. And the number is constantly growing. All this in the countryside, embedded in Brandenburg’s diverse cultural and natural landscape – and only 30 minutes from Berlin’s city centre. This is the Potsdam Science Park.
Come see for yourself!
Artificial intelligence is one of the big trending topics of our time. But what exactly can it do? Biotx.ai, a company based in the Potsdam Science Park, manages to recognize complex patterns in genomic data with its AI platform, enabling it to make precise predictions about the efficacy of new therapies. Their approach could radically shorten the time needed for such studies, revolutionizing an entire industry. Biotx.ai COO Christian Hebenstreit explains how this works in our interview.
In a way, BIOCYC is one of the hidden champions of the Potsdam Science Park. Producing peptides for both the pharmaceutical industry and research as well as antibodies for cancer diagnostics, their success allows them to build their own production building in the Potsdam Science Park. In our interview, BIOCYC CEO Alexander Gorczyza talks about antibodies for cancer diagnostics and why the Potsdam Science Park is the ideal location for the growing company.
Starting in January 2022, new companies and research groups will move into the newly built H-LAB in the Potsdam Science Park. Among them will be QMEDIS Analytics, a contract lab where drugs are not only analysed but also produced. In our interview, Dr. Dennis Stracke explains how the lab works and how drug printers could revolutionise the industry.
Scientists around the world are researching ways for a better treatment of cancer. One of them is offered by GILUPI, a company founded in 2006. With their product, medical personnel can extract cancer cells from the blood. Dr. Christian Jurinke has been the company’s CEO since 2018. In our interview, he explains why good diagnostics are crucial for cancer therapy and why they have moved into their new office at GO:IN 2 in the Potsdam Science Park.
Was the Big Bang really the beginning of our universe or is there more to find out? Dr. Jean-Luc Lehners, Leader of the ERC Research Group “Theoretical Cosmology” at the Max Planck Institute for Gravitational Physics (Albert Einstein Institute) and his team at the Potsdam Science Park are investigating these and other questions.